Tashjian A - Search Results

1

Pharmacokinetics of Subcutaneous Levetiracetam in Palliative Care Patients.

Papa P, Oricchio F, Ginés M, Maldonado C, Tashjian A, Ibarra M, Percovich M, Fagiolino P, Pedragosa B, Vázquez M. Papa P, et al. Among authors: tashjian a. J Palliat Med. 2021 Feb;24(2):248-251. doi: 10.1089/jpm.2019.0525. Epub 2020 Apr 8. J Palliat Med. 2021. PMID: 32267792

2

Sex and gender in medical education: a national student survey.

Jenkins MR, Herrmann A, Tashjian A, Ramineni T, Ramakrishnan R, Raef D, Rokas T, Shatzer J. Jenkins MR, et al. Among authors: tashjian a. Biol Sex Differ. 2016 Oct 14;7(Suppl 1):45. doi: 10.1186/s13293-016-0094-6. eCollection 2016. Biol Sex Differ. 2016. PMID: 27785347 Free PMC article.

3

A tear-free, SPF50 sunscreen product.

Yan XS, Riccardi G, Meola M, Tashjian A, SaNogueira J, Schultz T. Yan XS, et al. Among authors: tashjian a. Cutan Ocul Toxicol. 2008;27(3):231-9. doi: 10.1080/15569520802251072. Cutan Ocul Toxicol. 2008. PMID: 18988091 Clinical Trial.

4

On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).

Tashjian AH Jr, Goltzman D. Tashjian AH Jr, et al. J Bone Miner Res. 2008 Jun;23(6):803-11. doi: 10.1359/jbmr.080208. J Bone Miner Res. 2008. PMID: 18435577 Free article. No abstract available.

5

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.

Tashjian AH Jr, Gagel RF. Tashjian AH Jr, et al. J Bone Miner Res. 2006 Mar;21(3):354-65. doi: 10.1359/JBMR.051023. Epub 2005 Nov 11. J Bone Miner Res. 2006. PMID: 16491282 Free article. Review. No abstract available.

6

p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells.

Perletti G, Marras E, Dondi D, Osti D, Congiu T, Ferrarese R, de Eguileor M, Tashjian AH Jr. Perletti G, et al. Among authors: tashjian ah jr. Int J Cancer. 2005 Jan 1;113(1):42-53. doi: 10.1002/ijc.20535. Int J Cancer. 2005. PMID: 15386430

7

Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.

Tashjian AH Jr, Chabner BA. Tashjian AH Jr, et al. J Bone Miner Res. 2002 Jul;17(7):1151-61. doi: 10.1359/jbmr.2002.17.7.1151. J Bone Miner Res. 2002. PMID: 12096828 Free article. Review. No abstract available.

8

Modulation of recombinant human prostate-specific antigen: activation by Hofmeister salts and inhibition by azapeptides. Appendix: thermodynamic interpretation of the activation by concentrated salts.

Huang X, Knoell CT, Frey G, Hazegh-Azam M, Tashjian AH Jr, Hedstrom L, Abeles RH, Timasheff SN. Huang X, et al. Among authors: tashjian ah jr. Biochemistry. 2001 Oct 2;40(39):11734-41. doi: 10.1021/bi010364j. Biochemistry. 2001. PMID: 11570874

9

Production and characterization of an antiserum which recognizes the native receptor for thyrotropin-releasing hormone.

Chen F, Selinger Z, Marks P, Belinsky G, Tashjian AH Jr. Chen F, et al. Among authors: tashjian ah jr. Biochem Biophys Res Commun. 2001 Jul 20;285(3):742-50. doi: 10.1006/bbrc.2001.5140. Biochem Biophys Res Commun. 2001. PMID: 11453656

10

Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution.

Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F. Jin L, et al. Among authors: tashjian ah. J Biol Chem. 2000 Sep 1;275(35):27238-44. doi: 10.1074/jbc.M001134200. J Biol Chem. 2000. PMID: 10837469 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters